课题基金 / 基金详情

Mechanisms of Dok2 signaling during TGF beta-induced EMT

Mechanisms of Dok2 signaling during TGF beta-induced EMT
TGFβ 诱导 EMT 过程中 Dok2 信号传导机制
批准号:
92177455
负责人:
Dr. Elena Zimina
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2011-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
上皮-间质转化(Epithelial-mesenchymal transition, EMT)通常发生在胚胎形态发生过程中,但它也参与原发肿瘤向转移的进展。EMT是一个结构化上皮单位分解的过程,使细胞运动和形态发生。EMT涉及细胞-细胞外基质(ECM)相互作用的重塑。最近的进展为肿瘤进展中EMT的分子机制提供了更详细的了解,并强调了TGFβ在这一过程中的关键介导作用。Attisano博士的实验室最近发现了衔接蛋白Dok2,它是dok蛋白家族的一员,对TGFβ诱导ΕΜΤ至关重要。Attisano博士实验室的观察结果表明,Dok2在细胞- ECM相互作用的重组中起着重要作用。本研究旨在研究Dok2在TGFβ−诱导的EMT中发挥作用的分子机制。我们计划确定Dok2如何影响TGFβ依赖性EMT的细胞- ecm粘附和相关信号。了解Dok2在TGFβ−诱导的EMT中的功能与癌细胞的侵袭和转移特别相关。
英文摘要
Epithelial-mesenchymal transition (EMT) normally occurs during embryonic morphogenesis, but it is also involved in the progression of primary tumors towards metastases. EMT is a process of disaggregation of the structured epithelial units to enable cell movement and morphogenesis. EMT involves the remodeling of cell-extracellular matrix (ECM) interactions. Recent advances have provided a more detailed understanding of the molecular mechanisms governing EMT in tumor progression and have underlined the key mediating role of TGF beta (TGFβ) in this process. The laboratory of Dr. Attisano recently identified the adaptor protein Dok2, a member of Dok-protein family, to be essential for TGFβ−induced ΕΜΤ. Observations by Dr. Attisano s laboratory suggest an important role for Dok2 in the reorganization of cell- ECM interactions. The intended research aims to examine the molecular mechanisms whereby Dok2 functions in TGFβ−induced EMT. We plan to determine how Dok2 influences cell-ECM adhesion and associated signaling upon TGFβ−dependent EMT. Understanding of Dok2 function upon TGFβ− induced EMT is especially relevant for cancer cell invasion and metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于空间多组学揭示DOK2调控M2肺泡巨噬细胞双流死亡减轻脓毒症肺损伤的作用和机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    钱克俭
  • 依托单位: